Efficient automated synthesis of silicon-[18F]fluoride acceptor (SiFA)-based neuroendocrine tumour imaging agents via “non-anhydrous, minimally basic” (NAMB) radio-fluorination chemistry.
James Inkster, PhD
Active Projects
Elucidating the mechanisms for resistance to antiangiogenic therapy and metastasis in PanNETs
Yeonghwan Kim, PhD
Elucidating the origin of pulmonary carcinoids and molecular diversity of human neuroendocrine cells
Christin Kuo, MD
Elucidating the role of aging in GEP-NET development
Suzann Duan, PhD
Exploring new therapeutic avenues for SDHB-deficient metastatic PPGL
Qianjin Guo, PhD
Finding the causes of small intestinal neuroendocrine tumors
Matthew Meyerson, MD, PhD; Eric Nakakura, MD, PhD; Chrissie Thirlwell, MD, PhD
Harnessing ferroptosis initiating drugs to target GEP-NETs
Jeffrey Frost, PhD
Increasing the therapeutic window in PRRT with long-acting SSAs
Daphne de Vries-Huizing, PhD & Else Aalbersberg, PhD
Investigating GLP-1 receptor as a novel prognostic and therapeutic biomarker for pancreas NETs
Tiane Chen, MD, PhD, MSc
Mesenteric fibrosis in small intestinal neuroendocrine tumors: pathogenesis
Martyn Caplin, DM, FRCP